Cargando…
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels
Although many efforts have been made to elucidate the pathogenesis of COVID-19, the underlying mechanisms are yet to be fully uncovered. However, it is known that a dysfunctional immune response and the accompanying uncontrollable inflammation lead to troublesome outcomes in COVID-19 patients. Panne...
Autores principales: | Caufriez, Anne, Tabernilla, Andrés, Van Campenhout, Raf, Cooreman, Axelle, Leroy, Kaat, Sanz Serrano, Julen, Kadam, Prashant, dos Santos Rodrigues, Bruna, Lamouroux, Arthur, Ballet, Steven, Vinken, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146942/ https://www.ncbi.nlm.nih.gov/pubmed/35628472 http://dx.doi.org/10.3390/ijms23105664 |
Ejemplares similares
-
Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels
por: Cooreman, Axelle, et al.
Publicado: (2022) -
Pannexin1 channels in the liver: an open enemy
por: Van Campenhout, Raf, et al.
Publicado: (2023) -
In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach
por: Tabernilla, Andrés, et al.
Publicado: (2021) -
Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines
por: Leroy, Kaat, et al.
Publicado: (2021) -
Connexin-Based Channel Activity Is Not Specifically Altered by Hepatocarcinogenic Chemicals
por: Leroy, Kaat, et al.
Publicado: (2021)